title: Pulmonary hypertension in heart failure with preserved ejection fraction: a target for therapy?
authors: Aaron B
authors: AB
authors: Waxman
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004311:Double-Blind Method; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology*; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D058986:Phosphodiesterase 5 Inhibitors / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D015995:Prevalence; D011687:Purines / Q000008:administration & dosage; D012129:Respiratory Function Tests / Q000379:methods; D000068677:Sildenafil Citrate; D013318:Stroke Volume / Q000187:drug effects*; D013450:Sulfones / Q000008:administration & dosage*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate